GlassScriptPhysician profile
Ho Sun Choi
NPI 1053579169
$3,576.65
in general payments reported to CMS, 2019-2025
18 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.49 · 2020: $133 · 2021: $190 · 2022: $307 · 2023: $547 · 2024: $1,910 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,500 · Food and Beverage: $1,017 · Long Term Medical Supply Or Device Loan: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,500.00 |
| Food and Beverage | $1,017.08 |
| Long Term Medical Supply Or Device Loan | $360.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $1,500.00 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $560.93 | 2023-2024 | Lumera 700, Eq Workplace, Visumax |
| Alcon Vision LLC | $298.90 | 2024-2025 | Tryptyr, Rocklatan, Clareon |
| Sight Sciences, INC. | $219.37 | 2022-2023 | Tearcare System |
| Oyster Point Pharma, INC. | $190.44 | 2022-2024 | Tyrvaya |
| Amgen INC. | $143.75 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $107.82 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $103.92 | 2021 | |
| Horizon Therapeutics Plc | $95.49 | 2023 | Tepezza |
| Allergan, INC. | $75.66 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $69.93 | 2023-2024 | Xiidra, Vyzulta, Miebo |
| Kala Pharmaceuticals, INC. | $54.57 | 2020-2021 | |
| Glaukos Corporation | $40.53 | 2020-2022 | |
| Dompe US, INC. | $32.99 | 2025 | Oxervate |
| Harrow Eye, LLC | $22.73 | 2024 | Tobradex St, Ilevro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.76 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $18.46 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ho Sun Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.